Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks making big moves yesterday: Blackstone, Microsoft, Roku, Zscaler, and Axon

StockStory - Thu Apr 16, 8:00AM CDT
BX

BX Cover Image

Check out the companies making headlines yesterday:

Blackstone (NYSE:BX): Alternative investment manager Blackstone (NYSE:BX) rose by 3.3% on Wednesday after major banks and asset managers reported first-quarter earnings that surpassed Wall Street expectations. See our full article here.

Is now the time to buy Blackstone? Access our full analysis report here, it's free.

Microsoft (NASDAQ:MSFT): Technology giant Microsoft (NASDAQ:MSFT) rose by 5.1% on Wednesday after the technology sector rallied, pushing the Nasdaq near all-time highs, as investors cheered a potential de-escalation of geopolitical tensions in the Middle East amid a flurry of positive news in the artificial intelligence space. See our full article here.

Is now the time to buy Microsoft? Access our full analysis report here, it's free.

Roku (NASDAQ:ROKU): Streaming TV platform Roku (NASDAQ: ROKU) rose by 3.1% on Wednesday after sentiment improved following significant moves from heavyweights like Meta Platforms, which extended its partnership with Broadcom to deploy custom AI chips. See our full article here.

Is now the time to buy Roku? Access our full analysis report here, it's free.

Zscaler (NASDAQ:ZS): Cloud security platform Zscaler (NASDAQ:ZS) rose by 6.5% on Wednesday as markets benefited from a "risk-on" sentiment fueled by potential peace negotiations between the U.S. and Iran. See our full article here.

Is now the time to buy Zscaler? Access our full analysis report here, it's free.

Axon (NASDAQ:AXON): Self defense company AXON (NASDAQ:AXON) rose by 5.3% on Wednesday after TD Cowen reiterated its Buy rating on the stock with a price target of $825.00 See our full article here.

Is now the time to buy Axon? Access our full analysis report here, it's free.

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.